Stay updated on GSK2636771 Combo with Pembrolizumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the GSK2636771 Combo with Pembrolizumab in Melanoma Clinical Trial page.

Latest updates to the GSK2636771 Combo with Pembrolizumab in Melanoma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe footer revision label updated from v3.6.3 to v3.6.4, indicating a small version update to the page. The change is cosmetic and does not modify the study records or functionality.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedA new revision entry, Revision: v3.6.3, was added to the record history, replacing the previous v3.6.2. This updates the page's revision metadata without altering the study data.SummaryDifference0.1%

- Check37 days agoChange DetectedA new history entry (Version 35) with a Study Status update and revision v3.6.2 was added to the study record on 2026-06-24, and the older revision v3.6.0 was removed on 2026-06-10.SummaryDifference0.3%

- Check51 days agoChange DetectedRecruitment status updated to No longer looking for participants, indicating enrollment has closed for this study. This update is logged under Revision: v3.6.0 on 2026-06-10.SummaryDifference1%

- Check59 days agoChange DetectedThe history page displays a new site revision label, v3.5.5, replacing the previous v3.5.4, indicating an underlying platform update.SummaryDifference0.1%

- Check80 days agoChange DetectedA new revision tag (v3.5.4) was added to the study history, replacing the previous v3.5.3 tag. This reflects an administrative update to the record history.SummaryDifference0.1%

Stay in the know with updates to GSK2636771 Combo with Pembrolizumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GSK2636771 Combo with Pembrolizumab in Melanoma Clinical Trial page.